Which stock screener for free offers the best features?

The more practical question is whether the free tool lets an investor identify a business worth doing further work on before capital is committed.

That distinction matters because the screening process is not research itself. A screen is a way of shrinking a market from thousands of securities to a manageable set of companies whose unit economics, balance-sheet structure, and valuation deserve attention. For that first task, several free platforms are genuinely capable. They simply excel at different stages of the work.

For a fundamental investor, StockAnalysis.com is the strongest stock screener for free because of its unusual depth of financial filters and global coverage. For speed in U.S. equities, Finviz remains difficult to beat. For investors whose process begins with price structure, chart context, and international market breadth, TradingView has the broader ecosystem. There is no universal winner because there is no universal investment process.

The real price of a free screener: delayed data and gated workflow

Free screeners tend to impose restrictions in predictable places. The platform will usually allow investors to search a substantial universe, but it will constrain the actions that turn a one-time search into a repeatable system: saving custom screens, exporting a result set, creating alerts, applying proprietary rankings, or receiving live intraday prices.

This is not merely a product-design annoyance. It changes the kind of decision a screener can support.

A 15- or 20-minute delay is largely irrelevant to an investor looking for companies with five years of dividend growth, improving free-cash-flow margins, and a reasonable enterprise-value-to-EBIT multiple. Those characteristics do not change between 10:15 and 10:35 in the morning. But the same delay makes a tool unsuitable for intraday momentum work or rapid event trading. Investors sometimes blame a screener for being “slow” when the real issue is that they are asking a long-horizon research instrument to serve a short-horizon trading process.

The more consequential limitation is often export. Without a CSV file, a list of 60 candidates is harder to rank against a proprietary valuation model, portfolio holdings, or historical estimates. Without saved screens, a promising filter set becomes an exercise in reconstruction. And without multiple alerts, the tool is useful for discovery but less useful for ongoing surveillance.

A free screener is most valuable when it reduces noise before deep research; it becomes less valuable when an investor expects it to automate judgment.

The underlying economics are straightforward. Market data has licensing costs, while screening infrastructure requires servers, maintenance, and normalized financial data. Free stock scanner tools therefore function as an entry point into an ecosystem. That does not make them inferior. It simply means an investor should select the free tier for the bottleneck it solves, rather than treating filter count as an abstract measure of quality.

Finviz: the fastest visual route through U.S. equities

Finviz has endured since 2007 because it understands a simple truth about the early screening stage: investors often need to see a market quickly before they need to model it precisely.

Its free screener offers roughly 67 to 70 descriptive, fundamental, and technical filters for U.S. equities. The filter architecture is direct. An investor can combine market capitalization, valuation ratios, margins, growth rates, ownership measures, earnings dates, dividend yield, and a series of price-based conditions, then receive the results in a compact table or visual map. The outputs are not dressed up as a research terminal. They are designed to be scanned.

That matters on earnings-heavy weeks, when the objective may be to find companies with a combination such as:

1. Revenue and earnings growth that has not yet been fully reflected in a stretched valuation multiple.

2. A return-on-equity or operating-margin profile that suggests a durable business rather than a temporary cyclical spike.

3. Sufficient daily liquidity for a position to be built or exited without turning a portfolio decision into a market-impact problem.

4. An upcoming earnings date that creates a clear point for deeper work rather than an open-ended watchlist entry.

Finviz is especially efficient for investors who think in broad U.S. market cohorts. One can move from “large-cap industrial companies with expanding margins” to a short list quickly, and the visual heatmaps add context about sector leadership and market rotation without forcing the user into a charting-heavy workflow.

Its limitations are equally clear. The free tier’s market quotes and screener data are delayed by roughly 15 to 20 minutes. CSV export is reserved for Finviz Elite, whose listed pricing is $39.50 per month or $299.50 per year. That is a reasonable boundary for a platform built around rapid discovery, but it means the free product is not a robust database for investors who maintain large, repeatable quantitative universes.

Finviz also rewards investors who already know which ratios matter. Its filter menu can quickly produce plausible-looking value screens full of companies with low price-to-earnings ratios, but a low multiple is often the market’s summary of a real structural concern: a deteriorating moat trajectory, peak-cycle margins, high leverage, or weak pricing power. The screener will find the discount. It cannot tell an investor whether the discount is deserved.

TradingView: the broadest free environment for market context

TradingView approaches screening from the opposite direction. Its free product is less about a rapid U.S.-equity shortlist and more about keeping screening, charting, and cross-market observation in one environment.

The platform covers more than 14,000 stocks and 4,100 ETFs across global exchanges, with approximately 150 to 200 technical and fundamental metrics available for screening. That scale is meaningful for investors whose opportunity set is not confined to American large caps. A global investor can begin with country, exchange, sector, valuation, earnings performance, or price behavior, then open the chart and inspect the market’s response without changing tools.

For a business-focused investor, its value is not limited to technical analysis. Price action should not substitute for understanding capital allocation or competitive position. Yet price behavior can still be informative when it is used as context rather than a verdict. If a company reports stronger margins but the stock underperforms its peer group, the question is not whether a chart pattern “failed.” The better question is whether the market sees a deterioration in order quality, customer retention, inventory turns, or forward pricing that has not yet appeared in the headline earnings release.

TradingView makes this sort of comparative work relatively frictionless. It is particularly useful for:

• Comparing sector and country-level performance before assuming a company-specific thesis is responsible for a stock move.
• Identifying ETFs that provide a cleaner benchmark than a broad index for a specialized business.
• Searching across international listings where the relevant peer group may sit outside one domestic exchange.
• Moving from a filtered list into chart and financial-statement context without rebuilding the search elsewhere.

The free tier nevertheless has hard limits. Users are restricted to two indicators per chart, one server-side alert, and one saved chart layout. Those limits will not trouble an investor who uses charts as a secondary analytical layer. They become restrictive for an active trader monitoring multiple setups or a researcher running a large collection of recurring screens.

The practical conclusion is that TradingView is the best free choice for breadth and workflow integration, not necessarily for an investor who wants the deepest possible fundamental field set. It can identify a global opportunity universe elegantly; the final valuation work may still require another database or a personal model.

StockAnalysis.com: where free fundamental filters become genuinely useful

StockAnalysis.com is the most compelling no cost stock screener for investors who regard financial statements as the center of the process rather than a confirmation after the chart is chosen.

Launched in 2019, the platform has expanded its free screening coverage to more than 130,000 global stocks and funds and offers over 290 to 305 financial indicators and metrics. It does not require account registration just to use the basic screener. That combination of depth, geographic reach, and low friction is unusual.

The practical advantage is not simply that there are more filters. More filters can create the illusion of precision while encouraging users to optimize a screen around historical ratios that have little predictive value. The advantage is that a fundamental investor can ask more intelligent questions about business quality.

Instead of screening only for “low P/E” and “high dividend yield,” the user can build a more defensible starting universe around the interaction of growth, profitability, financial resilience, and valuation. A company with a modestly higher earnings multiple may be the better investment if it converts earnings to cash consistently, needs little incremental capital to grow, and has enough pricing power to defend margins through a weaker demand environment.

A disciplined fundamental screen might therefore combine several layers:

This is where StockAnalysis.com is strongest. It lets users move beyond generic free fundamental stock filters and form screens that resemble an actual analytical thesis. An investor looking for dividend compounders can distinguish a high current yield from sustained dividend growth supported by cash flow. Another investor can look for companies with operating leverage, falling leverage, and valuations that have not yet caught up with improving profitability.

There are caveats. Saving custom screens and exporting results require the Pro subscription, listed at $79 per year. That is a modest price relative to many market-data services, but it reveals the dividing line between exploration and process. The free version is excellent for building and reviewing a candidate list; Pro becomes more compelling once an investor wants a repeatable research pipeline, archived screens, and data moved into spreadsheets.

The best fundamental screen is not the one that returns the fewest stocks. It is the one that returns businesses whose economics can still be explained after the ratios are removed.

For most long-term investors, that is the decisive point. A screener with 300 metrics is useful only if the investor understands the causal relationship among them. Rising return on invested capital alongside stable gross margins and growing free cash flow says something coherent. A collection of isolated threshold values does not.

Stock Rover and Zacks: useful specialists with deliberate boundaries

Stock Rover is built for investors who want screening to connect more directly with portfolio analysis. Its free plan covers more than 8,500 North American stocks, 4,000 ETFs, and 40,000 mutual funds. That range makes it useful for an investor who evaluates funds and individual equities within the same allocation framework.

The paid tiers, however, are where Stock Rover’s more distinctive capabilities become available. Custom metric creation, advanced portfolio rebalancing, and screening across a universe of more than 500 to 650 metrics are restricted beyond the free plan, with paid pricing starting at $34 per month. For someone building a portfolio-level decision system, that may be justified. For a new investor searching for a handful of companies with strong cash generation and acceptable leverage, the free tier can still provide a valuable orientation.

Zacks occupies a different niche. Its free custom screener offers more than 130 to 145 data fields, which is enough for many basic fundamental and earnings-oriented searches. The important restriction is its proprietary Zacks Rank: screening on that indicator is limited to Premium subscribers. Investors should not confuse the availability of a brand’s research ecosystem with unrestricted access to its most differentiated signal.

This is a useful reminder that proprietary ratings deserve scrutiny even when they are available. A ranking system can be a helpful sorting device, but it should not be mistaken for a substitute for independent work on earnings quality, competitive dynamics, or valuation. The more a platform’s value proposition rests on a score the investor cannot deconstruct, the more carefully it should be used.

Yahoo Finance also deserves mention because of its accessibility and broad geographic footprint across 50 regions. Its free screener handles basic fundamental and technical filters well enough for casual discovery, but custom criteria are comparatively limited—roughly 15 to 40 data points—and the platform does not provide native CSV exports or complex conditional logic. It is a convenient starting point, not a serious destination for an investor building a systematic screening discipline.

Choosing the platform that fits the decision, not the marketing

The strongest free screener depends on where the investor loses time today.

Investors often begin by seeking the platform with the greatest number of filters. That is understandable, but filter abundance is only one part of the equation. Data freshness, universe coverage, the clarity of the interface, and the ability to preserve a repeatable process all matter. Most of all, the screen must fit the investment horizon.

A dividend-growth investor does not need a complex intraday scanner. A global investor should not accept a U.S.-only universe merely because the interface is familiar. And an investor who intends to calculate intrinsic value independently should be careful not to let a prepackaged rating system become the hidden owner of the thesis.

For the broadest fundamental work, StockAnalysis.com offers the best features available without payment: its metric depth and global coverage make it unusually capable as a first-pass research tool. Finviz remains the better answer for fast visual U.S. scanning, while TradingView is the more complete free environment for global market context and chart-based observation.

The larger lesson is less about software than about analytical discipline. A screener can reveal companies the market has overlooked, but it can also produce a polished list of businesses the market has correctly discounted. The investor’s edge begins only after the list is short: in determining whether revenue growth is durable, whether margins are earned rather than borrowed from the cycle, and whether management’s capital allocation can extend the company’s economic life.